when do you stop glp 1 Have to Stay on GLP-1 for Life? Treatment Duration Explained What Happens When You Stop
Description
Purpose of Review To discuss current literature and provide practical recommendations for the safe and effective use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in people with inflammatory bowel disease (IBD) and type 2 diabetes (T2D) and/or obesity
Reduced risk of side effects
GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped
Key Features
28G31G, 0.31.0 mL
